comprehensive -WSS

comprehensive

author：Wikipedia 2025-09-28 01:39:28 - browse：95

Gavel and Stethoscope due process — District courts will make the first round of decisions soon on challenges to Medicare's drug price negotiation program. APStock

WASHINGTON — Pharmaceutical companies’ efforts to scuttle President Biden’s signature health care achievement, empowering Medicare to negotiate prescription drug prices, will soon face their first big tests.

District court judges could soon weigh in on the litany of court cases that major companies filed against the government — shedding light on whether drugmakers have any hope of postponing the first parts of the negotiation process, scrapping it entirely, or sending the issue up to the Supreme Court.

It’s a major moment for the Biden administration, too, as the White House ramps up its efforts to take credit for the new changes in the 2024 election. The first round of legal decisions will play out in the thick of campaign season, attorneys told STAT.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical leaders decry Supreme Court decision on affirmative action
Next article： Peter Marks talks Operation Warp Speed for Rare Diseases

explore

WSS

Wellcome Trust names Røttingen as its new CEO

STAT Readout: Today's biotech news includes Sana and Amylyx

Readout Newsletter: Zepbound, Valneva's vaccine, and more

European regulators consider appeal over Amylyx ALS drug

White House drug czar issues call for 'recovery

Kidney disease boosts cardiac arrest risk for Hispanics, Latinos

leisure time

comprehensive

explore

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Better Therapeutics data on benefit with GLP

Supreme Court strikes down use of affirmative action

Humana CEO Bruce Broussard to step down in 2024

Duchenne breakthrough therapy leaves behind pioneering families

There’s no way to know how good AI health technologies are

Continuity nursing helped my family in our darkest PICU moments

Takeaways from AdvaMed, the largest medical devices conference

In Memoriam: Notable people who died in 2023

What's changing in Medicare's open enrollment this year?

entertainment

Takeaways from AdvaMed, the largest medical devices conference

Eight reasons why you should get an updated Covid vaccine

A letter from the executive editor: STAT UnitedHealth investigation

Peter Marks talks Operation Warp Speed for Rare Diseases

Carbon Health diabetes program, a test of data

What health policies could hitch a ride on a spending bill?

focus

entertainment

explore

hotspot